In a statement to the Guardian, a spokesperson for Hims & Hers said that their senior medical advisers see meaningful potential in several peptide therapies, and we welcome the FDAs move to evaluate regulated access to certain peptides for compounding, adding that they manufacture all peptides in-house, ensuring direct control over safety and quality control
PubMed Buckley, S.T., Bkdal, T.A., Vegge, A., Maarbjerg, S.J., Pyke, C., Ahnfelt-Rnne, J., Madsen, K.G., Schele, S.G., Alanentalo, T., Kirk, R.K., Pedersen, B.L., Skyggebjerg, R.B., Benie, A.J., Strauss, H.M., Wahlund, P.O., Bjerregaard, S., Farkas, E., Fekete, C., Sndergaard, F.L., Borregaard, J., Hartoft-Nielsen, M.L., & Knudsen, L.B
Sounds unbelievable
The effect of rapid decreases of blood pressure by different mechanisms on coronary flow and flow reserve in normal coronary arteries